Antiproliferative drug and delivery device

A - Human Necessities – 61 – L

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61L 31/16 (2006.01) A61F 2/06 (2006.01) A61K 31/436 (2006.01) A61K 31/727 (2006.01) A61K 45/06 (2006.01) A61F 2/00 (2006.01)

Patent

CA 2408719

A drug and drug delivery system may be utilized in the treatment of vascular disease. A local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography. The local delivery of the drugs or agents provides for increased effectiveness and lower systemic toxicity.

L'invention concerne un médicament et un système d'administration de médicaments pouvant être utilisés dans le traitement de maladies vasculaires. A cet effet, un système d'administration locale est enduit de rapamycine ou de tout autre médicament, agent ou composé approprié, avant d'être administré, de façon intraluminale, en vue du traitement et de la prévention de l'hyperplasie néo-intimale consécutive à une angiographie coronaire transluminale percutanée. L'administration locale desdits médicaments ou agents assure une meilleure efficacité et une toxicité systémique réduite.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antiproliferative drug and delivery device does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiproliferative drug and delivery device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiproliferative drug and delivery device will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1785862

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.